36503352|t|Cognitive improving actions of tofacitinib in a mouse model of Alzheimer disease involving TNF-alpha, IL-6, PI3K-Akt and GSK-3beta signalling pathway.
36503352|a|Aim and Objective: This current study investigated the significance of tofactinib in improving memory functions in a memory model of beta-amyloid (Abeta)-induced dementia.Material and Methods: Abeta1-42 was injected in the brain of mice using intracerebroventricular injection and after 14 days, the learning and memory was assessed on the Morris Water maze test. Mice were treated with tofactinib (10, 20, 30 mg/kg) two days prior to Abeta1-42 injection and 14 days after Abeta injection.Results: Treatment of tofactinib significantly improved the learning (decrease in day escape latency time [ELT]) and memory (increase in time spent in target quadrant). This drug also decreased the levels of T NF-alpha and IL-6 along with the rise in expression of p-Akt and p-GSK-3beta/GSK-3beta ratio in mice brain. Co-administration of LY294002 (P I3K inhibitor) or MK-2206 2HCl (Akt inhibitor) with tofactinib (30 mg/kg) obliterated the beneficial effects of the latter by increasing T NF-alpha and IL-6 levels along with decreasing the p-Akt expression and p-GSK-3beta/GSK-3beta ratio.Conclusion: It is concluded that tofactinib improves the condition of dementia of Alzheimer's type, possibly through down regulation of T NF-alpha and IL-6 and instigation of P I3K-Akt-p-GSK-3beta signalling system in the hippocampus of Abeta-treated mice.
36503352	31	42	tofacitinib	Chemical	MESH:C479163
36503352	48	53	mouse	Species	10090
36503352	63	80	Alzheimer disease	Disease	MESH:D000544
36503352	91	100	TNF-alpha	Gene	21926
36503352	102	106	IL-6	Gene	16193
36503352	113	116	Akt	Gene	11651
36503352	121	130	GSK-3beta	Gene	56637
36503352	222	232	tofactinib	Chemical	-
36503352	298	303	Abeta	Gene	11820
36503352	313	321	dementia	Disease	MESH:D003704
36503352	383	387	mice	Species	10090
36503352	515	519	Mice	Species	10090
36503352	538	548	tofactinib	Chemical	-
36503352	624	629	Abeta	Gene	11820
36503352	662	672	tofactinib	Chemical	-
36503352	863	867	IL-6	Gene	16193
36503352	907	910	Akt	Gene	11651
36503352	917	926	GSK-3beta	Gene	56637
36503352	927	936	GSK-3beta	Gene	56637
36503352	946	950	mice	Species	10090
36503352	979	987	LY294002	Chemical	MESH:C085911
36503352	1009	1021	MK-2206 2HCl	Chemical	-
36503352	1023	1026	Akt	Gene	11651
36503352	1043	1053	tofactinib	Chemical	-
36503352	1143	1147	IL-6	Gene	16193
36503352	1183	1186	Akt	Gene	11651
36503352	1204	1213	GSK-3beta	Gene	56637
36503352	1214	1223	GSK-3beta	Gene	56637
36503352	1263	1273	tofactinib	Chemical	-
36503352	1300	1308	dementia	Disease	MESH:D003704
36503352	1312	1323	Alzheimer's	Disease	MESH:D000544
36503352	1381	1385	IL-6	Gene	16193
36503352	1411	1414	Akt	Gene	11651
36503352	1417	1426	GSK-3beta	Gene	56637
36503352	1467	1472	Abeta	Gene	11820
36503352	1481	1485	mice	Species	10090
36503352	Negative_Correlation	MESH:C085911	11651
36503352	Positive_Correlation	MESH:C085911	56637
36503352	Association	MESH:C479163	56637
36503352	Association	MESH:D003704	56637
36503352	Association	MESH:D000544	21926
36503352	Association	MESH:D000544	11651
36503352	Positive_Correlation	MESH:D003704	11820
36503352	Association	MESH:D000544	16193
36503352	Association	MESH:C479163	21926
36503352	Positive_Correlation	MESH:C085911	16193
36503352	Association	MESH:C479163	MESH:D000544
36503352	Association	MESH:C479163	11651
36503352	Association	MESH:D000544	56637

